MSeqDR Mitochondrial Disease Portal


 
*:HP: HPO terms, UMDF: 1= Disease, ND: NAMDC terms.
  Most Studied  CPEO, Complex I Deficiency, COXPD1, Leigh, LHON, MELAS, MERRF, Myopathy, SANDO
Disease Browser
Parent Node:
expand
Mitochondrial Diseases (D028361)
Parent Node:
expand
Optic Atrophies, Hereditary (D015418)
..Starting node
..expand
Optic Atrophy, Hereditary, Leber (D029242)

       Child Nodes:
........expandMarsden syndrome (C536024)



 Sister Nodes: 
..expandBerk-Tabatznik syndrome (C535432)
..expandFriedreich Ataxia, So-Called, with Optic Atrophy and Sensorineural Deafness (C564999)
..expandGrowth retardation, Alopecia, Pseudoanodontia and Optic atrophy (C535642)
..expandHagemoser Weinstein Bresnick syndrome (C537626)
..expandKonigsmark Knox Hussels syndrome (C537214)
..expandMetaphyseal Dysplasia, Anetoderma, and Optic Atrophy (C565395)
..expandNecrotizing Encephalomyelopathy, Subacute, of Leigh, Adult (C563530)
..expandOptic atrophy 1 and deafness (C537124)  LSDB  L: 00657;
..expandOPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES (OMIM:616732)
..expandOPTIC ATROPHY 11 (OMIM:617302)
..expandOPTIC ATROPHY 2 (OMIM:311050)
..expandOptic Atrophy 4 (C565343)
..expandOptic atrophy 5 (C537126)
..expandOptic atrophy 6 (C537127)
..expandOptic Atrophy 7 (C567833)
..expandOPTIC ATROPHY 9 (OMIM:616289)
..expandOptic atrophy and cataract, autosomal dominant (C537128)
..expandOptic atrophy polyneuropathy deafness (C537129)
..expandOptic Atrophy Spastic Paraplegia Syndrome (C564084)
..expandOptic Atrophy with Demyelinating Disease of CNS (C563496)
..expandOptic Atrophy with Negative Electroretinograms (C563494)
..expandOptic Atrophy, Autosomal Dominant (D029241)  LSDB  L: 00073;
..expandOptic Atrophy, Deafness, Ophthalmoplegia, and Myopathy (C565117)
..expandOptic Atrophy, Hereditary, Leber (D029242) Child1  LSDB  L: 00072; 00492;
..expandSenior Loken Syndrome (C537580)
..expandSenior-Loken Syndrome 3 (C564637)
..expandSenior-Loken Syndrome 5 (C563763)
..expandSenior-Loken Syndrome 6 (C565708)
..expandSpastic Paraplegia, Optic Atrophy, And Dementia (C566679)
..expandSpastic Paraplegia, Optic Atrophy, Microcephaly, And Xy Sex Reversal (C566409)
..expandWolfram Syndrome (D014929) Child1
..expandWolfram Syndrome, Mitochondrial Form (C564012)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM,ClinVar, CTD
Term ID:9153
Name:Optic Atrophy, Hereditary, Leber
Definition:A maternally linked genetic disorder that presents in mid-life as acute or subacute central vision loss leading to central scotoma and blindness. The disease has been associated with missense mutations in the mtDNA, in genes for Complex I, III, and IV polypeptides, that can act autonomously or in association with each other to cause the disease. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/, MIM#535000 (April 17, 2001))
Alternative IDs:DO:DOID:705|OMIM:308905|OMIM:535000
ParentIDs:MESH:D015418|MESH:D028361
TreeNumbers:C10.292.700.225.500.400 |C10.574.500.662.400 |C11.270.564.400 |C11.640.451.451.400 |C16.320.290.564.400 |C16.320.400.630.400 |C18.452.660.670
Synonyms:Disease, Leber's |Diseases, Leber's |Hereditary Optic Neuroretinopathies |Hereditary Optic Neuroretinopathy |Leber Disease |Leber Hereditary Optic Atrophy |Leber Hereditary Optic Neuropathy |LEBER HEREDITARY OPTIC NEUROPATHY, MODIFIER OF |Leber Optic Atrophy |Leb
Slim Mappings:Eye disease|Genetic disease (inborn)|Metabolic disease|Nervous system disease
Reference: MedGen: D029242
MeSH: D029242
OMIM: 53500;
MSeqDR LSDB: 00072; 00492;  
Genes:
Phenotypes
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVar
NC_012920.1:m.8686T>C4508MT-ATP6Uncertain significance1569484231RCV000709918|RCV000854289; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104; MONDO:MONDO:0010794,MedGen:C1328349,OMIM:551500, Orphanet:644; MedGen:CN043634|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:25M86868686m.8686T>C-
NC_012920.1(MT-ATP6):m.8783G>A4508MT-ATP6Pathogenic/Likely pathogenic1603221804RCV000854322|RCV002249549; NMONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M87838783M:g.8783G>A-
NC_012920.1:m.8851T>C4508MT-ATP6Uncertain significance199476136RCV000010280|RCV000144005|RCV001268336|RCV001542705|RCV002221472; YMONDO:MONDO:0010774,MedGen:C1839022,OMIM:500003|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|MedGen:C3661900|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, OrphanetM88518851M:g.8851T>CClinGen:CA120598,OMIM:516060.0006C0023264 256000 Leigh syndrome;
NC_012920.1:m.8969G>A4508MT-ATP6Likely pathogenic794726857RCV000171545|RCV000854381|RCV002247579|RCV002260628; YMONDO:MONDO:0010782,MedGen:C4225415,OMIM:500011, Orphanet:2598|MONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:1M89698969m.8969G>AClinGen:CA199769,OMIM:516060.0012C4225415 500011 Myopathy, lactic acidosis, and sideroblastic anemia 3;
m.9101T>C4508MT-ATP6Benign199476134RCV000010277|RCV000854439; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M91019101M:g.9101T>CClinGen:CA340927,OMIM:516060.0003C0917796 535000 Leber's optic atrophy;
NC_012920.1:m.9176T>G4508MT-ATP6Likely pathogenic199476135RCV000010285|RCV000754649|RCV001542708|RCV001543462|RCV002221473; YMONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|MONDO:MONDO:0027069,MedGen:C3275684,OMIM:500015|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:C366M91769176M:g.9176T>GClinGen:CA340929,OMIM:516060.0011C0023264 256000 Leigh syndrome;
NC_012920.1:m.9205_9206del-1MT-ATP6;MT-CO3Likely pathogenic199476137RCV000010281|RCV002247301|RCV002260586; YMedGen:C4016603|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M92049205M:g.9204_9205delClinGen:CA120599,OMIM:516050.0007,OMIM:516060.0007C4016603 Seizures and lactic acidosis;
NC_012920.1:m.7444G>A-1MT-CO1;MT-TS1Likely benign199474822RCV000010299|RCV000010301|RCV000010300|RCV000854073|RCV001268422|RCV003319164; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0010779,MedGen:C3151897,OMIM:500008, Orphanet:90641|MONDO:MONDO:0010799,MedGen:C1838854,OMIM:580000, Orphanet:M74447444M:g.7444G>AClinGen:CA254851,OMIM:516030.0001,OMIM:590080.0006C1838854 580000 Aminoglycoside-induced deafness;
NC_012920.1:m.9237G>A4514MT-CO3Pathogenic1057516064RCV000408945|RCV002248640; NMONDO:MONDO:0005027,MeSH:D004827,MedGen:C0014544; Human Phenotype Ontology:HP:0006789,MedGen:C1852373; MedGen:C0424605|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M92379237M:g.9237G>AClinGen:CA16040652C0424605 Developmental delay;
m.9438G>A4514MT-CO3Benign267606611RCV000010286|RCV000854514; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M94389438M:g.9438G>AClinGen:CA254850,OMIM:516050.0001C0917796 535000 Leber's optic atrophy;
m.9804G>A4514MT-CO3Conflicting interpretations of pathogenicity200613617RCV000010287|RCV000756352|RCV000854582|RCV001196020; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:CN517202|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|M98049804M:g.9804G>AClinGen:CA340930,OMIM:516050.0002C0917796 535000 Leber's optic atrophy;
NC_012920.1(MT-CYB):m.14795T>C4519MT-CYBUncertain significance1603224896RCV000855158|RCV002287449; NMONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M1479514795M:g.14795T>C-
m.14831G>A4519MT-CYBBenign199795644RCV000055706|RCV000855165; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1483114831M:g.14831G>AClinGen:CA344826C0917796 535000 Leber's optic atrophy;
m.15150G>A4519MT-CYBPathogenic207460000RCV000010319|RCV000855232|RCV002247305; NHuman Phenotype Ontology:HP:0003546,MedGen:C0424551|MONDO:MONDO:0010780,MedGen:C3151898,OMIM:500009, Orphanet:254864|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M1515015150M:g.15150G>AClinGen:CA120619,OMIM:516020.0008C0424551 Exercise intolerance;
m.15257G>A4519MT-CYBBenign41518645RCV000010312|RCV000855257; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1525715257M:g.15257G>AClinGen:CA340931,OMIM:516020.0001C0917796 535000 Leber's optic atrophy;
NC_012920.1(MT-CYB):m.15437G>A4519MT-CYBUncertain significance878853058RCV000224435|RCV000764855|RCV000855292; NMedGen:CN517202|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104; MONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:25M1543715437M:g.15437G>AClinGen:CA10581343CN517202 not provided;
m.15579A>G4519MT-CYBUncertain significance207460002RCV000010321|RCV000855325|RCV002247306|RCV003153301; YMedGen:C0559758|MONDO:MONDO:0010780,MedGen:C3151898,OMIM:500009, Orphanet:254864|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:M1557915579M:g.15579A>GClinGen:CA120621,OMIM:516020.0010C0559758 Multisystem disorder;
m.15812G>A4519MT-CYBBenign200336777RCV000010313|RCV000855379; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1581215812M:g.15812G>AClinGen:CA254852,OMIM:516020.0002C0917796 535000 Leber's optic atrophy;
m.3376G>A4535MT-ND1Uncertain significance397515612RCV000056167|RCV002260605; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M33763376M:g.3376G>AClinGen:CA345259C0917796 535000 Leber's optic atrophy;
m.3394T>C4535MT-ND1Conflicting interpretations of pathogenicity41460449RCV000010375|RCV000507319|RCV000853650; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:CN517202|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M33943394M:g.3394T>CClinGen:CA340944,OMIM:516000.0004C0917796 535000 Leber's optic atrophy;
NC_012920.1:m.3460G>A4535MT-ND1Pathogenic199476118RCV000010370|RCV000143998|RCV000735416|RCV000757484|RCV003319165; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506||MedGen:C3661900|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0M34603460M:g.3460G>AClinGen:CA120646,OMIM:516000.0001C0917796 535000 Leber's optic atrophy;
m.3635G>A4535MT-ND1Likely pathogenic397515507RCV000055707|RCV002291214; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M36353635M:g.3635G>AClinGen:CA344827C0917796 535000 Leber's optic atrophy;
m.3697G>A4535MT-ND1Likely pathogenic199476122RCV000010385|RCV000010386|RCV000056168|RCV002221474|RCV003298030; YMONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|MONDO:MONDO:0010772,MedGen:C1839040,OMIM:500001, Orphanet:99718|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:M36973697M:g.3697G>AClinGen:CA120647,OMIM:516000.0012C0162671 540000 Juvenile myopathy, encephalopathy, lactic acidosis AND stroke;
m.3700G>A4535MT-ND1Uncertain significance397515508RCV000055708|RCV000415448|RCV002221484; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|Human Phenotype Ontology:HP:0000512,Human Phenotype Ontology:HP:0003285,MedGen:C0476397; Human Phenotype Ontology:HP:0001M37003700M:g.3700G>AClinGen:CA344828C1849688 Abnormal electroretinogram;
m.3733G>A4535MT-ND1Uncertain significance199476125RCV000010389|RCV002221475; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M37333733M:g.3733G>AClinGen:CA340950,OMIM:516000.0015C0917796 535000 Leber's optic atrophy;
m.3946G>A4535MT-ND1Pathogenic/Likely pathogenic199476123RCV000010387|RCV000853718|RCV001542704; NMONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:10M39463946M:g.3946G>AClinGen:CA254862,OMIM:516000.0013C0162671 540000 Juvenile myopathy, encephalopathy, lactic acidosis AND stroke;
m.4025C>T4535MT-ND1Benign397515509RCV000055709|RCV000853724; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M40254025M:g.4025C>TClinGen:CA344829C0917796 535000 Leber's optic atrophy;
m.4136A>G4535MT-ND1Benign199476121RCV000010378|RCV000853739; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M41364136M:g.4136A>GClinGen:CA254860,OMIM:516000.0006C0917796 535000 Leber's optic atrophy;
m.4160T>C4535MT-ND1Pathogenic199476119RCV000010372; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M41604160M:g.4160T>CClinGen:CA340942,OMIM:516000.0002C0917796 535000 Leber's optic atrophy;
m.4171C>A4535MT-ND1Uncertain significance28616230RCV000010384|RCV002260596; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M41714171M:g.4171C>AClinGen:CA340948,OMIM:516000.0010C0917796 535000 Leber's optic atrophy;
m.4216T>C4535MT-ND1Benign1599988RCV000010373|RCV000709875|RCV000853749; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:CN517202|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M42164216M:g.4216T>CClinGen:CA340943,OMIM:516000.0003C0917796 535000 Leber's optic atrophy;
m.4640C>A4536MT-ND2Benign387906426RCV000010366|RCV000853787; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M46404640M:g.4640C>AClinGen:CA340941,OMIM:516001.0003C0917796 535000 Leber's optic atrophy;
m.4917A>G4536MT-ND2Benign28357980RCV000010364|RCV000853834; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M49174917M:g.4917A>GOMIM:516001.0001,ClinGen:CA254858C0917796 535000 Leber's optic atrophy;
m.5244G>A4536MT-ND2Pathogenic199476115RCV000010365; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M52445244M:g.5244G>AClinGen:CA340940,OMIM:516001.0002C0917796 535000 Leber's optic atrophy;
m.10237T>C4537MT-ND3Benign1556423787RCV000055695|RCV000854632; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1023710237M:g.10237T>CClinGen:CA344819C0917796 535000 Leber's optic atrophy;
m.11253T>C4538MT-ND4Benign200145866RCV000055696|RCV000854721; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1125311253M:g.11253T>CClinGen:CA344820C0917796 535000 Leber's optic atrophy;
m.11696G>A4538MT-ND4Benign200873900RCV000010356|RCV000055697|RCV000854742; NMONDO:MONDO:0010772,MedGen:C1839040,OMIM:500001, Orphanet:99718|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:M1169611696M:g.11696G>AClinGen:CA120635,OMIM:516003.0003C1839040 500001 Leber hereditary optic neuropathy with dystonia;
m.11777C>A4538MT-ND4Likely pathogenic28384199RCV000010357|RCV000144013|RCV000854746|RCV002260594; YMONDO:MONDO:0100133,MedGen:C1838979, Orphanet:2609|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONM1177711777M:g.11777C>AClinGen:CA120636,OMIM:516003.0004C0023264 256000 Leigh syndrome;
NC_012920.1:m.11778G>A4538MT-ND4Pathogenic199476112RCV000010354|RCV000224219|RCV002260593|RCV002285007|RCV002288481; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:C3661900|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380|MedGen:CN169374|MONDO:MONDO:0010640,MedGM1177811778M:g.11778G>AClinGen:CA340939,OMIM:516003.0001C0917796 535000 Leber's optic atrophy;
m.10663T>C4539MT-ND4LLikely pathogenic1556423844RCV000010353|RCV003153302; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M1066310663M:g.10663T>CClinGen:CA340938,OMIM:516004.0002C0917796 535000 Leber's optic atrophy;
m.12338T>C4540MT-ND5Benign201863060RCV000022893|RCV000854787; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1233812338M:g.12338T>CClinGen:CA259737,OMIM:516005.0011C0917796 535000 Leber's optic atrophy;
NC_012920.1(MT-ND5):m.12425del4540MT-ND5Pathogenic1603223730RCV000854811|RCV002226500|RCV002249550; NMONDO:MONDO:0010780,MedGen:C3151898,OMIM:500009, Orphanet:254864|MONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, OrphanetM1241812418M:g.12418_12418del-
m.12706T>C4540MT-ND5Likely pathogenic267606893RCV000010338|RCV000144015|RCV002247308|RCV002260591; YMedGen:C1838951|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C07M1270612706M:g.12706T>CClinGen:CA120628,OMIM:516005.0003C0023264 256000 Leigh syndrome;
m.12811T>C4540MT-ND5Benign199974018RCV000055698|RCV000507393|RCV000854857|RCV003319177; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:C3661900|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C07M1281112811M:g.12811T>CClinGen:CA344821C0917796 535000 Leber's optic atrophy;
m.12848C>T4540MT-ND5Pathogenic267606899RCV000010350; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M1284812848M:g.12848C>TClinGen:CA340937,OMIM:516005.0009C0917796 535000 Leber's optic atrophy;
NC_012920.1(MT-ND5):m.12923G>A4540MT-ND5Likely pathogenic-1RCV003150916|RCV003150917|RCV003150918; NMONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|MONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:10M1292312923-
m.13045A>C4540MT-ND5Pathogenic267606895RCV000010340|RCV000010341|RCV000010342; NMONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:C1838951M1304513045M:g.13045A>CClinGen:CA120629,OMIM:516005.0005C0162671 540000 Juvenile myopathy, encephalopathy, lactic acidosis AND stroke;
NC_012920.1:m.13051G>A4540MT-ND5Pathogenic/Likely pathogenic1131692063RCV000495629|RCV000854887; YMONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M1305113051M:g.13051G>AClinGen:CA414816093C0751651 Mitochondrial diseases;
NC_012920.1(MT-ND5):m.13063G>A4540MT-ND5Pathogenic/Likely pathogenic1603224017RCV000854888|RCV002249551; NMONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M1306313063M:g.13063G>A-
NC_012920.1:m.13094T>C4540MT-ND5Pathogenic1603224029RCV000854891|RCV002291219|RCV002249552; YMONDO:MONDO:0010789,MedGen:C0162671,OMIM:540000, Orphanet:550|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, OrphanetM1309413094M:g.13094T>C-
m.13637A>G4540MT-ND5Benign200855215RCV000055699|RCV000854959; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1363713637M:g.13637A>GClinGen:CA344822C0917796 535000 Leber's optic atrophy;
m.13708G>A4540MT-ND5Benign28359178RCV000010336|RCV000854970; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1370813708M:g.13708G>AClinGen:CA340935,OMIM:516005.0001C0917796 535000 Leber's optic atrophy;
m.13730G>A4540MT-ND5Pathogenic387906425RCV000010337; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M1373013730M:g.13730G>AClinGen:CA340936,OMIM:516005.0002C0917796 535000 Leber's optic atrophy;
NC_012920.1(MT-ND5):m.13763C>T4540MT-ND5Likely benign1603224344RCV000854982|RCV001824897; NMONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|MedGen:CN043634; Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104; MONDO:MONDO:0010789,MedGen:C0162671,OMIM:54M1376313763M:g.13763C>T-
m.14279G>A4541MT-ND6Uncertain significance869025187RCV000055705|RCV000855082; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1427914279m.14279G>AClinGen:CA356575C0917796 535000 Leber's optic atrophy;
m.14325T>C4541MT-ND6Benign397515505RCV000055700|RCV000855092; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1432514325M:g.14325T>CClinGen:CA344823C0917796 535000 Leber's optic atrophy;
m.14459G>A4541MT-ND6Pathogenic199476105RCV000010326|RCV000010328|RCV000010327|RCV000144019|RCV001796715; YMONDO:MONDO:0010772,MedGen:C1839040,OMIM:500001, Orphanet:99718|MedGen:C1838951|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:M1445914459M:g.14459G>AClinGen:CA120625,OMIM:516006.0002C1839040 500001 Leber hereditary optic neuropathy with dystonia;
m.14482C>A4541MT-ND6Likely pathogenic199476108RCV000010332|RCV002260590; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M1448214482M:g.14482C>AClinGen:CA340934,OMIM:516006.0006C0917796 535000 Leber's optic atrophy;
m.14482C>G4541MT-ND6Likely pathogenic199476108RCV000055701|RCV003162433; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M1448214482M:g.14482C>GClinGen:CA344824C0917796 535000 Leber's optic atrophy;
NC_012920.1:m.14484T>C4541MT-ND6Pathogenic199476104RCV000010325|RCV000144018|RCV000223709|RCV003162238; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|MedGen:C3661900|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C07M1448414484M:g.14484T>CClinGen:CA340932,OMIM:516006.0001C0917796 535000 Leber's optic atrophy;
m.14487T>C4541MT-ND6Pathogenic199476109RCV000010333|RCV000010334|RCV000144020|RCV002247307|RCV003162239; YMedGen:C1838951|MedGen:C1838954|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D0M1448714487M:g.14487T>CClinGen:CA120627,OMIM:516006.0007C0023264 256000 Leigh syndrome;
m.14495A>G4541MT-ND6Likely pathogenic199476106RCV000010330|RCV002260588; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M1449514495M:g.14495A>GClinGen:CA340933,OMIM:516006.0004C0917796 535000 Leber's optic atrophy;
m.14498T>C4541MT-ND6Uncertain significance869025186RCV000055702|RCV000855115; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1449814498M:g.14498T>CClinGen:CA356574C0917796 535000 Leber's optic atrophy;
NC_012920.1(MT-ND6):m.14502T>C4541MT-ND6Benign201327354RCV000851178|RCV000855116; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0009723,MedGen:C0023264,OMIM:256000, Orphanet:506M1450214502M:g.14502T>C-
m.14568C>T4541MT-ND6Likely pathogenic397515506RCV000055703|RCV002260604; YHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MONDO:MONDO:0044970,MeSH:D028361,MedGen:C0751651, Orphanet:68380M1456814568M:g.14568C>TClinGen:CA344825C0917796 535000 Leber's optic atrophy;
m.14596A>T4541MT-ND6Pathogenic387906424RCV000010329|RCV000055704; NMONDO:MONDO:0010772,MedGen:C1839040,OMIM:500001, Orphanet:99718|Human Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104M1459614596M:g.14596A>TClinGen:CA120626,OMIM:516006.0003C1839040 500001 Leber hereditary optic neuropathy with dystonia;
NM_001377299.1(NDUFS2):c.268G>A (p.Ala90Thr)4720NDUFS2Likely pathogenic1553249704RCV000625868; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:10411611762621611762621:g.161176262G>AClinGen:CA343377955C0917796 535000 Leber's optic atrophy;
NM_006150.5(PRICKLE3):c.157C>T (p.Arg53Trp)4007PRICKLE3risk factor2065470015RCV001281698; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104X490403424904034249040342OMIM:300111.0001
NM_006269.2(RP1):c.4376A>G (p.Glu1459Gly)6101RP1Uncertain significance1315126444RCV001290414|RCV001366428; NHuman Phenotype Ontology:HP:0001086,Human Phenotype Ontology:HP:0001112,MONDO:MONDO:0010788,MedGen:C0917796,OMIM:535000, Orphanet:104|MedGen:C36619008555408185554081855540818-
MSeqDR Portal